NCT01224262 - A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 | Biotech Hunter

Enrollment

152

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Influenza

Interventions

BIOLOGICAL

Fluzone® (2010/2011 Inactivated Trivalent Influenza Vaccine)

A single vaccination of Fluzone alone

BIOLOGICAL

LIQ001 (0.45mg)

A single vaccination of 0.45 mg LIQ001

BIOLOGICAL

LIQ001 (1.8mg)

A single vaccination of 1.8 mg LIQ001

Trial Locations (1)

Accelovance - Melbourne, Melbourne